January 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreApril 21, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreApril 21, 2026
Based on market forecasts, the global clinical trial software market, projected at USD 0.9 billion in 2024, is expected to reach USD 3.23 billion by 2034, growing at a CAGR of 13.74% over the forecast period. The market is growing due to rising demand for digital tools that streamline trial design, data management, and regulatory compliance. Additi...
April 21, 2026
According to market projections, the behavioral health EHR software sector is expected to grow from USD 3.56 billion in 2024 to USD 14.22 billion by 2034, reflecting a CAGR of 14.85%. The market is growing due to rising demand for efficient mental health management and digital record-keeping. Additionally, increasing adoption of advanced tools for ...
April 21, 2026
The specialized clinical needs and unique regulatory compliance demands raise the importance of behavioral health-specific electronic health records. North America dominated the market in 2024 due to the expanded use of telehealth and remote care....
April 21, 2026
Market insights predict, the oncology automation industry is expected to grow from USD 2.82 billion in 2024 to USD 7.77 billion by 2034, driven by a CAGR of 10.68%. The oncology automation market is growing due to rising cases of cancer, leading to an increased need for automation. North America is dominating the market due to growing collaboration...
April 21, 2026
According to market projections, the intelligent medical software sector is expected to grow from USD 4.79 billion in 2025 to USD 22.33 billion by 2035, reflecting a CAGR of 16.64%. The artificial intelligence in healthcare market is rapidly growing due to technological innovation, increasing healthcare data, and rising demand for personalized me...
April 21, 2026
The Physical AI market is projected to grow from USD 5.41 billion in 2025 to USD 61.19 billion by 2034 at 31.26% CAGR. It covers surgical robotics, hospitals, rehabilitation, and diagnostics. Regional insights include NA (41.3%), EU, APAC, LA, MEA, with Asia-Pacific growing fastest. Key companies are Intuitive Surgical, CMR Surgical, Medtronic. Inc...
April 21, 2026
According to forecasts, the global AI in biopharmaceuticals market will grow from USD 1.55 billion in 2024 to USD 24.49 billion by 2034, with an expected CAGR of 32.27%. The implementation of artificial intelligence in biotechnology and pharmaceuticals helps to achieve speed and cost efficiency in drug discovery, precision medicine, clinical trials...
April 21, 2026
According to market projections, the AI in regulatory affairs sector is expected to grow from USD 1.6 billion in 2025 to USD 8.86 billion by 2035, reflecting a CAGR of 18.65%. The AI in regulatory affairs market is growing due to large data generation in drug discovery, which is easily processes using AI. North America leads the market because of s...
April 21, 2026
According to forecasts, the global RTLS in healthcare market will grow from USD 2.92 billion in 2025 to USD 13.94 billion by 2035, with an expected CAGR of 16.91%. The increasing adoption of advanced technology and the growing need for operational efficiencies drive the global market. North America dominated the global market owing to a robust heal...
April 21, 2026
The AI in patient scheduling software market is forecast to grow from USD 80.55 million in 2025 to USD 925.25 million by 2035, driven by a CAGR of 27.65% from 2025 to 2035. The growing need for automated scheduling and the increasing use of telemedicine bolster market growth. A robust healthcare infrastructure and favorable government support contr...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
